logo
episode-header-image
Mar 2023
8 m

Special Encore: U.S. Pharmaceuticals - T...

MORGAN STANLEY
About this episode
Original Release on February 6th, 2023: As new gene therapies are researched, developed and begin clinical trials, what hurdles must genetic medicine overcome before these therapies are commonly available? Head of U.S. Pharmaceuticals Terence Flynn and Head of U.S. Biotech Matthew Harrison discuss. 
Up next
Oct 30
The Curious Calm of Credit Markets
It appears that credit investors have gotten most of what they’ve wished for over the last decade. Our Global Head of Fixed Income Research Andrew Sheets considers whether there could be unintended consequences.Read more insights from Morgan Stanley.----- Transcript ----- Andrew ... Show More
4m 50s
Oct 29
How Digital Assets Are Rewiring Financial Markets
Our Head of Digital Asset Strategy Amy Oldenburg joins Global Digital Asset Strategist Felix Stratmann discuss how tokenization, regulation, and the convergence of traditional and digital finance could reshape global markets.Read more insights from Morgan Stanley.----- Transcript ... Show More
11m 26s
Oct 28
Signals to Watch in the U.S. Midterms
With Election Day a week away, our Head of U.S. Public Policy Research Ariana Salvatore and Wealth Management's Monica Guerra explain why the aftermath of the midterms may matter more to markets than who wins.Read more insights from Morgan Stanley.----- Transcript ----- Ariana Sa ... Show More
9m 18s
Recommended Episodes
Oct 2021
Gene Therapy – Behind the Science
<p>Gene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us ... Show More
25m 28s
Jan 2022
Starting a company to fight rare disease
Mapping the human genome led to big advances in diagnosing rare disease. But diagnosis is only the first step in dealing with an illness. So what do you do if your child is found to have a condition that has no treatment? We hear from Michelle Teng, a mother who co-founded a biot ... Show More
17m 28s
May 2019
a16z Podcast: The Economics of Expensive Medicines
<p>with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)</p> <p>The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, M ... Show More
33m 22s
Oct 2021
Gene Silencing Treatments
The future is here. Gene silencing medicines - which can fine tune how our DNA works - have held promise for decades. Now hundreds of thousands of people will get them in the UK. James speaks to a surgeon whose life and career have been saved by gene-silencing drugs and to resear ... Show More
28m 1s
Jan 2024
Unlocking Gene Therapy with Gaurav Shah
<p>Are rare diseases themselves rare? Neil deGrasse Tyson and comedian Chuck Nice learn about the science of gene therapy and how it can treat and potentially cure rare diseases with Gaurav Shah, CEO, Rocket Pharma.</p><p>NOTE: StarTalk+ Patrons can listen to this entire episode ... Show More
39m 56s
Mar 2025
Gene Therapy for Hearing Loss
Interview with Oliver F. Adunka, MD, MBA, and Vinay K. Rathi, MD, MBA, authors of Gene Therapy for Hearing Loss–Will the Price be Right? Hosted by Paul C. Bryson, MD, MBA. Related Content: Gene Therapy for Hearing Loss—Will the Price be Right? 
20m 8s
Listen to millions of songs and podcasts on Anghami